Apple Inc
XETRA:APC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Apple Inc
XETRA:APC
|
US |
|
Taboola.com Ltd
F:1FY
|
US |
|
Vera Therapeutics Inc
NASDAQ:VERA
|
US |
|
Abrdn PLC
LSE:ABDN
|
UK |
|
C
|
Cochlear Ltd
OTC:CHEOF
|
AU |
|
Kothari Fermentation and Biochem Ltd
BSE:507474
|
IN |
|
Flameret Inc
OTC:FLRE
|
US |
|
Creo Medical Group PLC
LSE:CREO
|
UK |
|
Longevity Health Holdings Inc
NASDAQ:XAGE
|
US |
|
E
|
El Capitan Precious Metals Inc
OTC:ECPN
|
US |
Wall Street
Price Targets
APC Price Targets Summary
Apple Inc
According to Wall Street analysts, the average 1-year price target for
APC
is 253.83 EUR
with a low forecast of 185.47 EUR and a high forecast of 313.88 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is APC's stock price target?
Price Target
253.83
EUR
According to Wall Street analysts, the average 1-year price target for
APC
is 253.83 EUR
with a low forecast of 185.47 EUR and a high forecast of 313.88 EUR.
What is Apple Inc's Revenue forecast?
Projected CAGR
9%
For the last 13 years the
compound annual growth rate for
Apple Inc's revenue is
8%.
The projected
CAGR
for the next 3 years is
9%.
What is Apple Inc's Operating Income forecast?
Projected CAGR
10%
For the last 13 years the
compound annual growth rate for
Apple Inc's operating income is
7%.
The projected
CAGR
for the next 3 years is
10%.
What is Apple Inc's Net Income forecast?
Projected CAGR
11%
For the last 13 years the
compound annual growth rate for
Apple Inc's net income is
8%.
The projected
CAGR
for the next 3 years is
11%.
